Abstract Background Neurotransmitters deficits in Frontotemporal Dementia (FTD) are still
poorly understood. Better knowledge of neurotransmitters impairment, especially in …

Recent studies have reported early cerebellar and subcortical impact in the disease
progression of genetic frontotemporal dementia (FTD) due to microtubule‐associated …

Background: The overlap between frontotemporal dementia (FTD) and primary psychiatric
disorders has been brought to light by reports of prominent neuropsychiatric symptoms …

Objectives The clinical heterogeneity of frontotemporal dementia (FTD) complicates
identification of biomarkers for clinical trials that may be sensitive during the prediagnostic …

Biomarkers that can predict disease progression in individuals with genetic frontotemporal
dementia are urgently needed. We aimed to identify whether baseline MRI-based grey and …

This article examines the evolution in understanding of frontotemporal dementia (FTD)
during the last four decades. A central theme is the recognition of heterogeneity. Originally …

Introduction We aimed to assess episodic memory in genetic frontotemporal dementia (FTD)
with the Free and Cued Selective Reminding Test (FCSRT). Methods The FCSRT was …

Background and Objectives Disease-modifying therapeutic trials for genetic frontotemporal
dementia (FTD) are underway, but sensitive cognitive outcome measures are lacking. The …

Frontotemporal lobar degeneration (FTLD), also known as frontotemporal dementia (FTD),
results in a progressive decline in executive function, leading to behavioral changes, speech …

Introduction Frontotemporal dementia (FTD) is a common cause of early-onset dementia
with a significant genetic component, as underlined by the recent identification of repeat …